Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

Estudio del pleuston y bafon de las lagunas de Chascomús y Yalca (Provincia de Buenos Aires)

Fil: Ronderos, Ricardo Arturo. Centro de Estudios en Parasitología y Vectores (CEPAVE); Facultad de Ciencias Naturales y Museo; Universidad Nacional de La PlataFil: Bulla, L.A.. Fil: Schnack, Juan Alberto. División Entomología; Facultad de Ciencias Naturales y Museo; Universidad Nacional de La PlataFil: Ves Losada, Julio C.

The use of quantitative real time polymerase chain reaction to quantify some rumen bacterial strains in an in vitro rumen system

The aim of this work was to quantify four rumen bacterial strains (Butyrivibrio fibrisolvens, Ruminococcus albus, Streptococcus bovis, Megasphaera elsdenii) in an in vitro batch rumen fermentative system by quantitative real time polymerase chain reaction (qPCR). The experiment was a 2 72 factorial arrangement with two types of liquid rumen, collected from dairy cows (DC) and fattening bulls (FB) and two types of fermentation substrate (forage:concentrate ratios, 75:25 and 25:75) and was replicated in two fermentation runs. Fermentation fluids from FB compared to those from DC had lower pH, higher total VFA concentrations (averages of 0 and 24 h samplings, 6.70 vs 7.04 and 72.6 vs 42.7 mmol/l P<0.001) and contained less acetic (P=0.014) and more propionic (P<0.01) and butyric (P=0.029) acids. The two types of substrates incubated produced very small differences in the end fermentation products. B. fibrosolvens concentrations were higher (P<0.001) in the DC fermentation fluids compared to that from bulls (averages of 0 and 24 h sampling times, 3.47 vs 1.38 x109 copies /mL), while M. elsdenii was detected only in FB fermentation fluids. R. albus and S. bovisconcentrations were not different between the two types of rumen liquid. With the only exception for B. fibrosolvens, bacteria strains considered in this study increased their concentrations in the fermentation fluid during the 24 h of in vitro incubation